Updated COVID-19 vaccines are already showing up on some pharmacy and health provider shelves. But a key program that paid for the vaccines when people lacked coverage is out of money. So those who are under-insured or uninsured could pay up to $200 for the booster.
The good news is, the risk of developing Long COVID has dropped significantly since the start of the pandemic—and, according to a new study, we have COVID-19 vaccines to thank for much of this decline. The bad news is, the risk of developing this post-acute infection syndrome remains substantial.
A new study in the Journal of Public Health suggests that it is more effective to emphasize the harms that come from not getting vaccinated rather than emphasizing the benefits of vaccination at the individual or community level.
Recent Comments